CIR / CII

How to determine CIR eligibility for clinical trials in human pharmaceuticals and medical devices?

Our experts can help you determine whether your clinical, epidemiological and medical device research is eligible for the CIR.
What does the PLF 2025 have to say about the CII, the JEI status and the CICo?

What does the PLF 2025 have to say about the future of the CII, the JEI status and the CICo?

Find out what impact the PLF 2025 will have on the CII, the JEI and JEIC statuses and the CICo?
CIR 2024 Guide

Guide CIR 2024: what are the major changes compared with the 2023 edition?

Discover the key changes described in the CIR 2024 guide vs. the 2023 edition, analyzed by our experts.

When should you apply for CIR approval renewal in 2024?

Discover the deadline for applying for CIR approval in 2024
The Importance of Finding Partners

Collaborative innovation: the importance of finding partners

Find out how to save time in identifying partners for your innovation projects
New legislation to combat organized tax fraud

New legislation to combat organized tax fraud

Discover the new law to combat organized tax fraud, including fictitious tax credits
Nouvelle jurisprudence sur l’éligibilité au CIR des sous-projets liée à l'indissociabilité des travaux

New case law on CIR eligibility of sub-projects linked to the inseparability of works

Find out about new case law on the CIR eligibility of sub-projects linked to the inseparability of work.

CIR and case law: importance of the state of the art, eligibility of an employee treated as an engineer and expert appraisal costs

Find out about case law clarifications on the CIR concerning the state of the art, staff eligibility and expert appraisal costs.
Jurisprudence: Rejection of R&D expenditure capitalized and declared as depreciation in the CIR tax base

Jurisprudence: Rejection of R&D expenditure capitalized and declared as depreciation in the CIR tax base

Discover new case law on the subject of capitalized R&D expenses declared as depreciation allowances in the CIR.
mews partners: CIR mission support

Mews partners: adding value to R&D expenditure

Find out how Mews Partners has ensured 100% validation of declared expenses and optimized the structuring of R&D projects over the years thanks to G.A.C. Group.
Services
Services
Sectors
Sectors

Newsletter G.A.C.